Access the full text.
Sign up today, get DeepDyve free for 14 days.
Wei Han, Zhongshuai Xin, Zhiqiang Zhao, Wenqing Bao, Xihua Lin, B. Yin, Jizong Zhao, Jiangang Yuan, B. Qiang, Xiaozhong Peng (2013)
RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3.The Journal of clinical investigation, 123 5
S. Khandhadia, A. Lotery (2010)
Oxidation and age-related macular degeneration: insights from molecular biologyExpert Reviews in Molecular Medicine, 12
M. Carroll (2004)
A protective role for innate immunity in systemic lupus erythematosusNature Reviews Immunology, 4
M. Józsi, P. Zipfel (2008)
Factor H family proteins and human diseases.Trends in immunology, 29 8
D. Fearon, R. Locksley (1996)
The Instructive Role of Innate Immunity in the Acquired Immune ResponseScience, 272
John Cardone, G. Friec, C. Kemper (2011)
CD46 in innate and adaptive immunity: an updateClinical & Experimental Immunology, 164
A. Risitano (2012)
Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders.Immunobiology, 217 11
M. Józsi, J. Prechl, Z. Bajtay, A. Erdei (2002)
Complement Receptor Type 1 (CD35) Mediates Inhibitory Signals in Human B Lymphocytes1The Journal of Immunology, 168
S. Waggoner, M. Cruise, R. Kassel, Y. Hahn (2007)
gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathwayThe Journal of Immunology, 178
M. Pickering, H. Cook (2008)
Translational Mini‐Review Series on Complement Factor H: Renal diseases associated with complement factor H: novel insights from humans and animalsClinical & Experimental Immunology, 151
B. Rohrer, B. Coughlin, Kannan Kunchithapautham, Q. Long, S. Tomlinson, Kazue Takahashi, V. Holers (2011)
The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization.Molecular immunology, 48 6-7
T. Cooke, E. Hurd, H. Jasin, J. Bienenstock, J. Bienenstock, M. Ziff (1975)
Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues.Arthritis and rheumatism, 18 6
S. Perkins, T. Goodship (2002)
Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.Journal of molecular biology, 316 2
C. Fang, V. Frémeaux-Bacchi, M. Liszewski, G. Pianetti, M. Noris, T. Goodship, J. Atkinson (2007)
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.Blood, 111 2
H. Regele (2010)
Faculty Opinions recommendation of Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.
M. Carroll, V. Holers (2005)
Innate autoimmunity.Advances in immunology, 86
M. Markiewski, R. DeAngelis, F. Benencia, Salome Ricklin-Lichtsteiner, A. Koutoulaki, C. Gerard, G. Coukos, John Lambris (2008)
Modulation of the anti-tumor immune response by complementNature immunology, 9
S. Boackle, K. Culhane, Jared Brown, M. Haas, L. Bao, R. Quigg, V. Holers (2004)
CR1/CR2 Deficiency Alters IgG3 Autoantibody Production and IgA Glomerular Deposition in the MRL/lpr Model of SLEAutoimmunity, 37
A. Prodeus, Siegfried Goerg, Li-Ming Shen, O. Pozdnyakova, Lisa Chu, E. Alicot, Christopher Goodnow, Michael Carroll (1998)
A critical role for complement in maintenance of self-tolerance.Immunity, 9 5
Michael Holers, W. Arend, N. Banda, Kazue Takahashi, Allyson Wood (2007)
Pathogenic Complement Activation in Collagen Antibody- Induced Arthritis in Mice Requires Amplification by the Alternative Pathway1The Journal of Immunology, 179
A. Davis (1988)
C1 inhibitor and hereditary angioneurotic edema.Annual review of immunology, 6
Kaisa Happonen, D. Heinegård, T. Saxne, A. Blom (2012)
Interactions of the complement system with molecules of extracellular matrix: relevance for joint diseases.Immunobiology, 217 11
Kirstin Matthews, Stacey Mueller-Ortiz, R. Wetsel (2004)
Carboxypeptidase N: a pleiotropic regulator of inflammation.Molecular immunology, 40 11
G. Firestein (2003)
Evolving concepts of rheumatoid arthritisNature, 423
A. Risitano, R. Notaro, Ludovica Marando, B. Serio, D. Ranaldi, E. Seneca, P. Ricci, F. Alfinito, A. Camera, G. Gianfaldoni, A. Amendola, C. Boschetti, E. Bona, G. Fratellanza, F. Barbano, F. Rodeghiero, A. Zanella, A. Iori, C. Selleri, L. Luzzatto, B. Rotoli (2009)
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab.Blood, 113 17
J. Jordan, M. Montalto, G. Stahl (2001)
Inhibition of Mannose-Binding Lectin Reduces Postischemic Myocardial Reperfusion InjuryCirculation: Journal of the American Heart Association, 104
C. Werning (1983)
[Rheumatoid arthritis].Medizinische Monatsschrift fur Pharmazeuten, 6 12
M. Gadjeva, Kazue Takahashi, S. Thiel (2004)
Mannan-binding lectin--a soluble pattern recognition molecule.Molecular immunology, 41 2-3
S. Christiansen, B. Zuraw (2009)
Update on therapeutic developments for hereditary angioedema.Allergy and asthma proceedings, 30 5
M. Berger, I. Gaither, M. Frank (1981)
Complement receptors.Clinical immunology reviews, 1 4
G. Girardi, D. Yarilin, J. Thurman, V. Holers, J. Salmon (2006)
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restrictionThe Journal of Experimental Medicine, 203
C. Nester, P. Brophy (2013)
Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseasesCurrent Opinion in Pediatrics, 25
C. Strey, M. Markiewski, D. Mastellos, Ruxandra Tudoran, L. Spruce, L. Greenbaum, John Lambris (2003)
The Proinflammatory Mediators C3a and C5a Are Essential for Liver RegenerationThe Journal of Experimental Medicine, 198
V. Runza, W. Schwaeble, D. Männel (2008)
Ficolins: novel pattern recognition molecules of the innate immune response.Immunobiology, 213 3-4
Carmen van, den Berg, Claire Harris (2005)
‘‘Homologous restriction’’ in complement lysis: roles of membrane complement regulatorsXenotransplantation, 12
S. Lea, Steven Johnson (2012)
Putting the structure into complement.Immunobiology, 217 11
J. Thurman, A. Lenderink, Pamela Royer, Kathrin Coleman, Jian Zhou, John Lambris, R. Nemenoff, R. Quigg, V. Holers (2007)
C3a Is Required for the Production of CXC Chemokines by Tubular Epithelial Cells after Renal Ishemia/Reperfusion1The Journal of Immunology, 178
Daniel Ricklin, G. Hajishengallis, Kun Yang, John Lambris (2010)
Complement: a key system for immune surveillance and homeostasisNature Immunology, 11
K. Reid, M. Turner (2005)
Mammalian lectins in activation and clearance mechanisms involving the complement systemSpringer Seminars in Immunopathology, 15
V. Holers, B. Rohrer, S. Tomlinson (2013)
CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation.Advances in experimental medicine and biology, 735
Songqing He, C. Atkinson, F. Qiao, K. Cianflone, Xiao-ping Chen, S. Tomlinson (2009)
A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice.The Journal of clinical investigation, 119 8
M. Huber-Lang, J. Sarma, F. Zetoune, D. Rittirsch, T. Neff, Stephanie McGuire, John Lambris, R. Warner, M. Flierl, L. Hoesel, F. Gebhard, J. Younger, S. Drouin, R. Wetsel, P. Ward (2006)
Generation of C5a in the absence of C3: a new complement activation pathwayNature Medicine, 12
Z. Kaya, M. Afanasyeva, Yan Wang, K. Dohmen, Jens Schlichting, T. Tretter, D. Fairweather, V. Holers, N. Rose (2001)
Contribution of the innate immune system to autoimmune myocarditis: a role for complementNature Immunology, 2
S. Sacks (2010)
Complement fragments C3a and C5a: The salt and pepper of the immune responseEuropean Journal of Immunology, 40
Alexandros Drosos (2004)
Epidemiology of rheumatoid arthritis.Autoimmunity reviews, 3 Suppl 1
J. Inal, K. Hui, S. Miot, S. Lange, M. Ramirez, B. Schneider, G. Krueger, J. Schifferli (2005)
Complement C2 Receptor Inhibitor Trispanning: A Novel Human Complement Inhibitory Receptor12The Journal of Immunology, 174
B. Nilsson, K. Ekdahl (2012)
Complement Diagnostics: Concepts, Indications, and Practical GuidelinesClinical and Developmental Immunology, 2012
K. Kuhn, Cassy Cozine, Beren Tomooka, W. Robinson, V. Holers (2008)
Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.Molecular immunology, 45 10
Stuart Linton, B. Morgan (1999)
Complement activation and inhibition in experimental models of arthritis.Molecular immunology, 36 13-14
J. Schmidtko, S. Peine, Youssef El-Housseini, M. Pascual, P. Meier (2013)
Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.American journal of kidney diseases : the official journal of the National Kidney Foundation, 61 2
S. Perkins, R. Nan, Keying Li, Sanaullah Khan, Ami Miller (2012)
Complement factor H-ligand interactions: self-association, multivalency and dissociation constants.Immunobiology, 217 2
E. Holmquist, M. Okrój, B. Nodin, K. Jirström, A. Blom (2013)
Sushi domain‐containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertaseThe FASEB Journal, 27
R. Baelder, B. Fuchs, W. Bautsch, J. Zwirner, J. Köhl, H. Hoymann, T. Glaab, V. Erpenbeck, N. Krug, A. Braun (2005)
Pharmacological Targeting of Anaphylatoxin Receptors during the Effector Phase of Allergic Asthma Suppresses Airway Hyperresponsiveness and Airway Inflammation1The Journal of Immunology, 174
T. Phan, I. Grigorova, T. Okada, J. Cyster (2007)
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cellsNature Immunology, 8
Jason Song, Inyong Hwang, Kyung Cho, Michael Garcia, Arthur Kim, Tiffany Wang, T. Lindstrom, Annette Lee, T. Nishimura, Lei Zhao, J. Morser, M. Nesheim, Stuart Goodman, David Lee, S. Bridges, P. Gregersen, Lawrence Leung, William Robinson (2011)
Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis.The Journal of clinical investigation, 121 9
C. Fang, Xinhua Zhang, T. Miwa, W. Song (2009)
Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production.Blood, 114 5
E. Jorge, Joseph Caesar, T. Malik, Mitali Patel, Matthew Colledge, Steven Johnson, S. Hakobyan, B. Morgan, C. Harris, M. Pickering, S. Lea (2013)
Dimerization of complement factor H-related proteins modulates complement activation in vivoProceedings of the National Academy of Sciences, 110
C. Kemper, D. Hourcade (2008)
Properdin: New roles in pattern recognition and target clearance.Molecular immunology, 45 16
N. Banda, Stephanie Hyatt, A. Antonioli, Jason White, M. Glogowska, Kazue Takahashi, T. Merkel, Gregory Stahl, Stacey Mueller-Ortiz, Rick Wetsel, W. Arend, V. Holers (2012)
Role of C3a Receptors, C5a Receptors, and Complement Protein C6 Deficiency in Collagen Antibody-Induced Arthritis in MiceThe Journal of Immunology, 188
W. Song (2012)
Crosstalk between Complement and Toll-Like ReceptorsToxicologic Pathology, 40
A. Sahu, John Lambris (2001)
Structure and biology of complement protein C3, a connecting link between innate and acquired immunityImmunological Reviews, 180
Daniel Ricklin, John Lambris (2013)
Progress and Trends in Complement Therapeutics.Advances in experimental medicine and biology, 735
M. Parkes, A. Cortes, D. Heel, M. Brown (2013)
Genetic insights into common pathways and complex relationships among immune-mediated diseasesNature Reviews Genetics, 14
N. Banda, J. Thurman, Damian Kraus, Allyson Wood, M. Carroll, W. Arend, V. Holers (2006)
Alternative Complement Pathway Activation Is Essential for Inflammation and Joint Destruction in the Passive Transfer Model of Collagen-Induced Arthritis1The Journal of Immunology, 177
Michelle Elvington, Yuxiang Huang, B. Morgan, F. Qiao, N. Rooijen, C. Atkinson, S. Tomlinson (2012)
A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer.Blood, 119 25
T. Malik, P. Lavin, E. Jorge, K. Vernon, K. Rose, M. Patel, M. Leeuw, J. Neary, P. Conlon, M. Winn, M. Pickering (2012)
A hybrid CFHR3-1 gene causes familial C3 glomerulopathy.Journal of the American Society of Nephrology : JASN, 23 7
P. Lachmann, N. Hughes-Jones (2005)
Initiation of complement activationSpringer Seminars in Immunopathology, 7
M. Noris, G. Remuzzi (2007)
Translational Mini‐Review Series on Complement Factor H: Therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritisClinical & Experimental Immunology, 151
K. Gehrs, Don Anderson, L. Johnson, G. Hageman (2006)
Age‐related macular degeneration—emerging pathogenetic and therapeutic conceptsAnnals of Medicine, 38
A. Tortajada, Hugo Yébenes, C. Abarrategui-Garrido, J. Anter, J. García-Fernández, Ruben Martinez-Barricarte, María Alba-Domínguez, T. Malik, R. Bedoya, Rocío Pérez, M. Trascasa, M. Pickering, C. Harris, P. Sánchez-Corral, O. Llorca, S. Córdoba (2013)
C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.The Journal of clinical investigation, 123 6
B. Morgan, P. Gasque (1997)
Extrahepatic complement biosynthesis: where, when and why?Clinical & Experimental Immunology, 107
B. Nilsson, K. Ekdahl (2012)
The tick-over theory revisited: is C3 a contact-activated protein?Immunobiology, 217 11
J. Salmon, C. Heuser, M. Triebwasser, M. Liszewski, D. Kavanagh, L. Roumenina, D. Branch, T. Goodship, V. Frémeaux-Bacchi, J. Atkinson (2011)
Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE CohortPLoS Medicine, 8
A. Barratt-Due, S. Pischke, O. Brekke, E. Thorgersen, E. Nielsen, T. Espevik, M. Huber-Lang, T. Mollnes (2012)
Bride and groom in systemic inflammation--the bells ring for complement and Toll in cooperation.Immunobiology, 217 11
S. Córdoba, A. Tortajada, C. Harris, B. Morgan (2012)
Complement dysregulation and disease: from genes and proteins to diagnostics and drugs.Immunobiology, 217 11
M. Markiewski, John Lambris (2009)
Is complement good or bad for cancer patients? A new perspective on an old dilemma.Trends in immunology, 30 6
J. Cohen-Solal, B. Diamond (2011)
Lessons from an anti-DNA autoantibody.Molecular immunology, 48 11
N. Bora, S. Kaliappan, P. Jha, Qin Xu, J. Sohn, D. Dhaulakhandi, H. Kaplan, P. Bora (2006)
Complement Activation via Alternative Pathway Is Critical in the Development of Laser-Induced Choroidal Neovascularization: Role of Factor B and Factor H1The Journal of Immunology, 177
R. Yanai, A. Thanos, K. Connor (2012)
Complement involvement in neovascular ocular diseases.Advances in experimental medicine and biology, 946
R. Silasi-Mansat, Hua Zhu, N. Popescu, G. Peer, G. Sfyroera, P. Magotti, L. Ivanciu, C. Lupu, T. Mollnes, F. Taylor, G. Kinasewitz, John Lambris, F. Lupu (2010)
Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.Blood, 116 6
J. Laufer, Y. Katz, J. Passwell (2001)
Extrahepatic synthesis of complement proteins in inflammation.Molecular immunology, 38 2-3
Daniel Ricklin (2012)
Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy.Immunobiology, 217 11
Xinhua Zhang, Yuko Kimura, C. Fang, Lin Zhou, G. Sfyroera, John Lambris, R. Wetsel, T. Miwa, W. Song (2007)
Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo.Blood, 110 1
R. Taylor, M. Lindorfer (2014)
The role of complement in mAb-based therapies of cancer.Methods, 65 1
M. Uszewski, T. Farries, D. Lublin, I. Rooney, J. Atkinson (1996)
Control of the complement system.Advances in immunology, 61
L. Bao, M. Haas, Damian Kraus, B. Hack, J. Rakstang, V. Holers, R. Quigg (2003)
Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice.Journal of the American Society of Nephrology : JASN, 14 3
M. Pangburn, N. Rawal, V. Ferreira, M. Atkinson (2007)
Polyanion-induced self-association of complement factor H: possible mechanism of host protection from an innate immune system (53.11)The Journal of Immunology
C. Karsten, J. Köhl (2012)
The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.Immunobiology, 217 11
M. Nozaki, B. Raisler, E. Sakurai, J. Sarma, S. Barnum, John Lambris, Yali Chen, Kang Zhang, B. Ambati, J. Baffi, J. Ambati (2005)
Drusen complement components C3a and C5a promote choroidal neovascularization.Proceedings of the National Academy of Sciences of the United States of America, 103 7
E. Neumann, S. Barnum, I. Tarner, J. Echols, M. Fleck, M. Judex, F. Kullmann, J. Mountz, J. Schölmerich, S. Gay, U. Müller-Ladner (2002)
Local production of complement proteins in rheumatoid arthritis synovium.Arthritis and rheumatism, 46 4
P. Lachmann (2009)
The amplification loop of the complement pathways.Advances in immunology, 104
M. Strainic, Ethan Shevach, F. An, F. Lin, M. Medof (2012)
Absent C3a and C5a receptor signaling into CD4+ T cells enables auto-inductive TGF-β1 signaling and induction of Foxp3+ T regulatory cellsNature immunology, 14
S. Cashman, Kasmir Ramo, R. Kumar‐Singh (2011)
A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular DegenerationPLoS ONE, 6
M. Botto, M. Kirschfink, P. Macor, M. Pickering, R. Würzner, Francesco Tedesco (2009)
Complement in human diseases: Lessons from complement deficiencies.Molecular immunology, 46 14
M. Carroll (2000)
The role of complement in B cell activation and tolerance.Advances in immunology, 74
P. Jha, P. Bora, N. Bora (2007)
The role of complement system in ocular diseases including uveitis and macular degeneration.Molecular immunology, 44 16
K. Helmy, K. Katschke, N. Gorgani, Noelyn Kljavin, Mike Elliott, Laura Diehl, S. Scales, N. Ghilardi, M. Campagne (2006)
CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating PathogensCell, 124
V. Holers (2005)
Complement receptors and the shaping of the natural antibody repertoireSpringer Seminars in Immunopathology, 26
H. Sekine, T. Kinser, F. Qiao, Efraín Martínez, E. Paulling, P. Ruiz, G. Gilkeson, S. Tomlinson (2011)
The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.Arthritis and rheumatism, 63 4
S. Pittock, V. Lennon, A. McKeon, J. Mandrekar, B. Weinshenker, C. Lucchinetti, O. O'toole, D. Wingerchuk (2013)
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot studyThe Lancet Neurology, 12
D. Hourcade, V. Holers, J. Atkinson (1989)
The regulators of complement activation (RCA) gene cluster.Advances in immunology, 45
Ke Li, S. Sacks, Wuding Zhou (2007)
The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies.Molecular immunology, 44 16
V. Holers (2003)
The complement system as a therapeutic target in autoimmunity.Clinical immunology, 107 3
Margaret Elliott, T. Jarmi, P. Ruiz, Yuanyuan Xu, V. Holers, G. Gilkeson (2004)
Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.Kidney international, 65 1
(2012)
The CD46-Jagged1 interaction is critical for human TH1 immunity
C. Skerka, P. Zipfel (2008)
Complement factor H related proteins in immune diseases.Vaccine, 26 Suppl 8
K. Joseph, L. Kulik, B. Coughlin, Kannan Kunchithapautham, M. Bandyopadhyay, S. Thiel, N. Thielens, V. Holers, B. Rohrer (2013)
Oxidative Stress Sensitizes Retinal Pigmented Epithelial (RPE) Cells to Complement-mediated Injury in a Natural Antibody-, Lectin Pathway-, and Phospholipid Epitope-dependent Manner*The Journal of Biological Chemistry, 288
M. Fonseca, Rahasson Ager, Shu-Hui Chu, Ozkan Yazan, S. Sanderson, F. LaFerla, Stephen Taylor, T. Woodruff, A. Tenner (2009)
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer’s Disease1The Journal of Immunology, 183
Anne-lie Ståhl, L. Sartz, D. Karpman (2011)
Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.Blood, 117 20
M. Botto, M. Walport (2002)
C1q, autoimmunity and apoptosis.Immunobiology, 205 4-5
E. Brown (1991)
Complement receptors and phagocytosis.Current opinion in immunology, 3 1
M. Heurich, Ruben Martinez-Barricarte, Nigel Francis, Dawn Roberts, S. Córdoba, B. Morgan, C. Harris, D. Fearon (2011)
Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease riskProceedings of the National Academy of Sciences, 108
D. Tuveson, J. Ahearn, Alan Matsumoto, D. Fearon (1991)
Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complexThe Journal of Experimental Medicine, 173
Wenxian Fu, G. Wojtkiewicz, R. Weissleder, C. Benoist, D. Mathis (2012)
Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imagingNature immunology, 13
M. Gadjeva, A. Verschoor, M. Brockman, Heather Jezak, L. Shen, D. Knipe, M. Carroll (2002)
Macrophage-Derived Complement Component C4 Can Restore Humoral Immunity in C4-Deficient Mice1The Journal of Immunology, 169
V. Holers, J. Thurman (2004)
The alternative pathway of complement in disease: opportunities for therapeutic targeting.Molecular immunology, 41 2-3
P. Ward (2009)
Functions of C5a receptorsJournal of Molecular Medicine, 87
M. Pickering, E. Jorge, Ruben Martinez-Barricarte, S. Recalde, A. García-Layana, K. Rose, J. Moss, M. Walport, H. Cook, S. Córdoba, M. Botto, M. Pickering (2007)
Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domainsThe Journal of Experimental Medicine, 204
Christian Schulz, Bernd Engelmann, Steffen Massberg (2013)
Crossroads of coagulation and innate immunity: the case of deep vein thrombosisJournal of Thrombosis and Haemostasis, 11
M. Markiewski, B. Nilsson, K. Ekdahl, T. Mollnes, John Lambris (2007)
Complement and coagulation: strangers or partners in crime?Trends in immunology, 28 4
F. Fakhouri, V. Frémeaux-Bacchi, L. Noël, H. Cook, M. Pickering (2010)
C3 glomerulopathy: a new classificationNature Reviews Nephrology, 6
P. Gros, F. Milder, B. Janssen (2008)
Complement driven by conformational changesNature Reviews Immunology, 8
H. Sekine, P. Ruiz, G. Gilkeson, S. Tomlinson (2011)
The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition.Molecular immunology, 49 1-2
M. Pangburn (2002)
Cutting Edge: Localization of the Host Recognition Functions of Complement Factor H at the Carboxyl-Terminal: Implications for Hemolytic Uremic Syndrome1The Journal of Immunology, 169
K. Rose, D. Paixão-Cavalcante, J. Fish, Anthony Manderson, T. Malik, A. Bygrave, Tao Lin, Steven Sacks, Mark Walport, H. Cook, M. Botto, Matthew Pickering (2008)
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.The Journal of clinical investigation, 118 2
C. Collard, M. Montalto, W. Reenstra, J. Buras, G. Stahl (2001)
Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1.The American journal of pathology, 159 3
U. Amara, M. Flierl, D. Rittirsch, A. Klos, Hui Chen, B. Acker, U. Brückner, B. Nilsson, F. Gebhard, John Lambris, M. Huber-Lang (2010)
Molecular Intercommunication between the Complement and Coagulation SystemsThe Journal of Immunology, 185
Min Wang, J. Krauss, H. Domon, K. Hosur, S. Liang, P. Magotti, M. Triantafilou, K. Triantafilou, John Lambris, G. Hajishengallis (2010)
Microbial Hijacking of Complement–Toll-Like Receptor CrosstalkScience Signaling, 3
J. Ogembo, L. Kannan, I. Ghiran, A. Nicholson‐Weller, R. Finberg, G. Tsokos, J. Fingeroth (2013)
Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.Cell reports, 3 2
A. Doni, C. Garlanda, B. Bottazzi, S. Meri, P. Garred, A. Mantovani (2012)
Interactions of the humoral pattern recognition molecule PTX3 with the complement system.Immunobiology, 217 11
X. Qing, P. Redecha, M. Burmeister, S. Tomlinson, V. D’Agati, R. Davisson, J. Salmon (2011)
Targeted inhibition of complement activation prevents features of preeclampsia in mice.Kidney international, 79 3
P. Zipfel, T. Hallström, K. Riesbeck (2013)
Human complement control and complement evasion by pathogenic microbes--tipping the balance.Molecular immunology, 56 3
P. Zipfel, C. Skerka, J. Hellwage, S. Jokiranta, Seppo Meri, V. Brade, P. Kraiczy, M. Noris, G. Remuzzi (2001)
Factor H family proteins: on complement, microbes and human diseases.Biochemical Society transactions, 30 Pt 6
R. Wetsel (1995)
Structure, function and cellular expression of complement anaphylatoxin receptors.Current opinion in immunology, 7 1
A. Hughes, N. Orr, H. Esfandiary, M. Diaz-Torres, T. Goodship, U. Chakravarthy (2006)
A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degenerationNature Genetics, 38
A. Humbles, B. Lu, Christy Nilsson, C. Lilly, E. Israel, Y. Fujiwara, N. Gerard, C. Gerard (2000)
A role for the C3a anaphylatoxin receptor in the effector phase of asthmaNature, 406
M. Carroll (1998)
The role of complement and complement receptors in induction and regulation of immunity.Annual review of immunology, 16
P. Dempsey, Michael Allison, S. Akkaraju, C. Goodnow, D. Fearon (1996)
C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired ImmunityScience, 271
B. Stevens, N. Allen, L. Vazquez, G. Howell, K. Christopherson, Navid Nouri, K. Micheva, A. Mehalow, A. Huberman, Benjamin Stafford, A. Sher, A. Litke, John Lambris, Stephen Smith, S. John, B. Barres (2007)
The Classical Complement Cascade Mediates CNS Synapse EliminationCell, 131
Nurul Alam, V. Ferreira, M. Atkinson, M. Pangburn, N. Rawal, Claudio Cortés (2009)
Polyanion-Induced Self-Association of Complement Factor H1The Journal of Immunology, 182
A. Blom, B. Villoutreix, B. Dahlbäck (2004)
Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?Molecular immunology, 40 18
M. Papadopoulos, A. Verkman (2012)
Aquaporin 4 and neuromyelitis opticaThe Lancet Neurology, 11
I. Calero, I. Sanz (2010)
Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning?Discovery medicine, 10 54
H. Hawlisch, Y. Belkaid, R. Baelder, David Hildeman, C. Gerard, J. Köhl (2005)
C5a negatively regulates toll-like receptor 4-induced immune responses.Immunity, 22 4
Kazue Takahashi, Wei-Chuan Chang, Minoru Takahashi, V. Pavlov, Yumi Ishida, Laura Bonte, Lei Shi, T. Fujita, G. Stahl, E. Cott (2011)
Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation.Immunobiology, 216 1-2
H. Müller-Eberhard (1988)
Molecular organization and function of the complement system.Annual review of biochemistry, 57
W. Rosse, J. Nishimura (2003)
Clinical Manifestations of Paroxysmal Nocturnal Hemoglobinuria: Present State and Future ProblemsInternational Journal of Hematology, 77
Zheng Liu, A. Davidson (2011)
BAFF and selection of autoreactive B cells.Trends in immunology, 32 8
J. Thurman, L. Kulik, Heather Orth, Maria Wong, B. Renner, S. Sargsyan, Lynne Mitchell, D. Hourcade, J. Hannan, James Kovacs, B. Coughlin, Alex Woodell, Matthew Pickering, B. Rohrer, V. Holers (2013)
Detection of complement activation using monoclonal antibodies against C3d.The Journal of clinical investigation, 123 5
William Arend (2001)
The innate immune system in rheumatoid arthritis.Arthritis and rheumatism, 44 10
K. Davies, A. Peters, H. Beynon, M. Walport (1992)
Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.The Journal of clinical investigation, 90 5
H. Morgan, C. Schmidt, M. Guariento, B. Blaum, D. Gillespie, A. Herbert, D. Kavanagh, H. Mertens, D. Svergun, Conny Johansson, D. Uhrín, P. Barlow, J. Hannan (2011)
Structural basis for engagement by complement factor H of C3b on a self surfaceNature structural & molecular biology, 18
R. Rother, S. Rollins, C. Mojcik, R. Brodsky, L. Bell (2007)
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuriaNature Biotechnology, 25
Although new activation and regulatory mechanisms are still being identified, the basic architecture of the complement system has been known for decades. Two major roles of complement are to control certain bacterial infections and to promote clearance of apoptotic cells. In addition, although inappropriate complement activation has long been proposed to cause tissue damage in human inflammatory and autoimmune diseases, whether this is indeed true has been uncertain. However, recent studies in humans, especially those using newly available biological therapeutics, have now clearly demonstrated the pathophysiologic importance of the complement system in several rare diseases. Beyond these conditions, recent genetic studies have strongly supported an injurious role for complement in a wide array of human inflammatory, degenerative, and autoimmune diseases. This review includes an overview of complement activation, regulatory, and effector mechanisms. It then focuses on new understandings gained from genetic studies, ex vivo analyses, therapeutic trials, and animal models as well as on new research opportunities.
Annual Review of Immunology – Annual Reviews
Published: Mar 21, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.